Venezuela exposure profile · WST · Health Care

West Pharmaceutical Services (WST): Venezuela Exposure Check

Independent audit of West Pharmaceutical Services's exposure to Venezuela — OFAC SDN matches, SEC filings, and Caracas Research news corpus.

Indirect exposure

West Pharmaceutical Services has disclosed Venezuela-related items in 1 recent SEC filing.

West Pharmaceutical Services has filed 1 recent SEC document (10-K) containing Venezuela / PdVSA / CITGO references. This is the company's own disclosure and is the strongest evidence of material exposure short of an OFAC designation. See the SEC filings section below for excerpts.

Ticker
WST
S&P 500 sector
Health Care
Headquarters
Exton, Pennsylvania
OFAC matches
0
EDGAR filings
1
Last refreshed
2026-04-25

OFAC Venezuela SDN matches

No entry on the OFAC Venezuela SDN list contains West Pharmaceutical Services as of the most recent OFAC scrape. Always re-verify with OFAC Sanctions Search before transacting.

SEC filings disclosing Venezuela items

West Pharmaceutical Services has filed 1 recent SEC document containing references to Venezuela, PdVSA, CITGO or related terms. These are the company's own disclosures.

SEC EDGAR · accession 0000105770-25-000013

Federal Register & news corpus mentions

No Federal Register notice or analyzed news article in our corpus references West Pharmaceutical Services in a Venezuela context. Search the live sanctions tracker or the daily briefing index for ad-hoc context.

US trade-restriction screening (BIS / Commerce)

OFAC sanctions are one of four major US restricted-party registers a counterparty needs to be screened against. The Department of Commerce’s Bureau of Industry and Security (BIS) maintains three more — the Entity List, the Denied Persons List, and the Unverified List — under the Export Administration Regulations (15 CFR Part 744). All four are consolidated by the International Trade Administration into the single Consolidated Screening List. The links below deep-search each register for West Pharmaceutical Services; a US-domiciled public company will not normally appear, but the official lookup is the only authoritative way to confirm.

Methodology. This page combines four signals: (1) a hand-curated map of S&P 500 Venezuela exposure maintained by Caracas Research analysts; (2) fuzzy substring matching against every Venezuela-program OFAC SDN designation (refreshed twice daily); (3) the SEC EDGAR full-text search across the company's 10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months; (4) a scan of our own analyzed-news corpus and US Federal Register notices. Last refreshed 2026-04-25. This is not legal or compliance advice; always verify with primary sources and qualified sanctions counsel before transacting.

Frequently asked questions

Is West Pharmaceutical Services (WST) sanctioned by OFAC?
As of April 2026, West Pharmaceutical Services (WST) is not listed on the OFAC Venezuela SDN list. No direct or subsidiary entity match was found in our scan against the live US Treasury SDN feed. Always re-verify against the official OFAC Sanctions Search before relying on this for a compliance decision.
Is West Pharmaceutical Services (WST) on a US trade-restriction list (BIS Entity List, Denied Persons List, or Unverified List)?
No. West Pharmaceutical Services is a US-domiciled public company and does not appear on the Bureau of Industry and Security (BIS) Entity List, Denied Persons List, or Unverified List as of April 2026. These export-control lists, administered by the US Department of Commerce under the Export Administration Regulations (EAR / 15 CFR Part 744), target foreign end-users — not US-headquartered issuers. Re-verify in the official Consolidated Screening List before relying on this for a compliance decision.
Does West Pharmaceutical Services have Venezuela revenue exposure?
West Pharmaceutical Services has disclosed Venezuela-related items in 1 recent SEC filing. West Pharmaceutical Services has filed 1 recent SEC document (10-K) containing Venezuela / PdVSA / CITGO references. This is the company's own disclosure and is the strongest evidence of material expo
Has West Pharmaceutical Services disclosed Venezuela in its SEC filings?
West Pharmaceutical Services has filed 1 recent SEC document containing Venezuela-related references (searched across 10-K, 10-Q, 8-K, 20-F, and 6-K filings on EDGAR over the last 24 months). See the SEC filings section on the page for the matched excerpts and links to each filing.

Useful tools

Other Health Care S&P 500 companies

6 in this sector cohort